Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 10;13(3):463-469.
doi: 10.1021/acsmedchemlett.1c00633. eCollection 2022 Mar 10.

Novel Pyridazin-3(2 H)-one-Based Guanidine Derivatives as Potential DNA Minor Groove Binders with Anticancer Activity

Affiliations

Novel Pyridazin-3(2 H)-one-Based Guanidine Derivatives as Potential DNA Minor Groove Binders with Anticancer Activity

María Carmen Costas-Lago et al. ACS Med Chem Lett. .

Abstract

Novel aryl guanidinium analogues containing the pyridazin-3(2H)-one core were proposed as minor groove binders (MGBs) with the support of molecular docking studies. The target dicationic or monocationic compounds, which show the guanidium group at different positions of the pyridazinone moiety, were synthesized using the corresponding silyl-protected pyridazinones as key intermediates. Pyridazinone scaffolds were converted into the adequate bromoalkyl derivatives, which by reaction with N,N'-di-Boc-protected guanidine followed by acid hydrolysis provided the hydrochloride salts 1-14 in good yields. The ability of new pyridazin-3(2H)-one-based guanidines as DNA binders was studied by means of DNA UV-thermal denaturation experiments. Their antiproliferative activity was also explored in three cancer cell lines (NCI-H460, A2780, and MCF-7). Compounds 1-4 with a bis-guanidinium structure display a weak DNA binding affinity and exhibit a reasonable cellular viability inhibition percentage in the three cancer cell lines studied.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Examples of classical amidine MGBs with antibacterial, antiparasitic, or anticancer activities.
Figure 2
Figure 2
General structure of some guanidine and 2-aminoimidazole dicationic prototypes previously reported by Rozas’ group.
Figure 3
Figure 3
Compounds proposed in this study as potential MGBs.
Figure 4
Figure 4
Best pose obtained in the docking of compound 1 to the DNA minor groove model (dodecanucleotide d(CGCGAATTCGCG)2, PDB: 1D64), with a G-score of −8.9 kcal/mol, using a flexible-rigid approach and the Autodock Vina program. Green lines and numbers indicate HBs, and HB distances are in Å.
Scheme 1
Scheme 1. Preparation of Bis-guanidinium Derivatives 14
Reagents and conditions: (a) 1,3-bis(tert-butoxycarbonyl)guanidine, K2CO3, DMF, 50 °C, 2 h, 60% (52 and 53), 61% (54), 70% (55); (b) HCl 4 M in 1,4-dioxane, dioxane, 55 °C, 5 h, 80% (1), 83% (2), 85% (3), 94% (4).
Scheme 2
Scheme 2. Preparation of Monoguanidinium Derivatives 514
Reagents and conditions: (a) 1,3-bis(tert-butoxycarbonyl)guanidine, K2CO3, DMF, 50 °C, 2 h, 57% (76), 55% (77), 59% (78), 60% (79), 94% (80), 84% (81), 90% (82), 83% (83),62% (84); (b) HCl 4 M in 1,4-dioxane, dioxane, 55 °C, 5 h, 77% (5), 92% (6), 86% (7), 33% (8) and 46% (9), 92% (10), 89% (11), 92% (12), 90% (13), 99% (14).

Similar articles

Cited by

References

    1. Rahman A.; O'Sullivan P.; Rozas I. Recent developments in compounds acting in the DNA minor groove. Med. Chem. Commun. 2019, 10, 26–40. 10.1039/C8MD00425K. - DOI - PMC - PubMed
    1. Cai X.; Gray P. J. Jr; von Hoff D. D. DNA minor groove binders: back in the groove. Cancer Treat. Rev. 2009, 35, 437–450. 10.1016/j.ctrv.2009.02.004. - DOI - PubMed
    1. Goodsell D.; Dickerson R. E. Isohelical analysis of DNA groove-binding drugs. J. Med. Chem. 1986, 29, 727–733. 10.1021/jm00155a023. - DOI - PubMed
    1. Chen X.; Ramakrishnan B.; Sundaralingam M. Crystal structures of B-form DNA-RNA chimers complexed with distamycin. Nat. Struct. Biol. 1995, 2, 733–735. 10.1038/nsb0995-733. - DOI - PubMed
    1. Neidle S. Crystallographic insights into DNA minor groove recognition by drugs. Biopolymers 1997, 44, 105–121. 10.1002/(SICI)1097-0282(1997)44:1<105::AID-BIP7>3.0.CO;2-Z. - DOI